Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

CNBX — CNBX Pharmaceuticals Inc. SEC Filings | FilingIndex

CNBXOTC

CNBX Pharmaceuticals Inc.

Pharmaceutical Preparations · NV · CIK 1343009

CNBX Pharmaceuticals Inc. develops and commercializes innovative pharmaceutical products

+ Watch View on EDGAR ↗

181

Total filings

Jun 24, 2026

Last filing

08/31

Fiscal year end

All 8-K · 79 10-Q · 54 10-K · 17 10-Q/A · 9 SC 13D · 5 S-1 · 4 10-K/A · 4 S-1/A · 4

8-KMaterial AgreementMar 17, 2026 8-KMaterial AgreementJan 30, 2025 8-KAuditor ChangeMar 22, 2024 8-KExecutive ChangeFeb 8, 2023 8-KExecutive ChangeDec 29, 2022 8-K

Similar companies

Comparable business profile · signals at a glance

MBXMBX Biosciences, Inc.$1.7B+2.5%RGNXREGENXBIO Inc.$344.3M+1.3%DWTXDogwood Therapeutics, Inc.$51.8M-9.6%HELPCYBIN INC.$214.5M-3.9%CTNMContineum Therapeutics, Inc.

Executive Change

Jul 25, 2022

8-KBylaw AmendmentMay 13, 2022

8-KBylaw Amendment · Company UpdateMar 28, 2022

8-KMaterial Agreement · New Debt / ObligationMar 16, 2022

8-KMaterial AgreementFeb 17, 2022

8-KExecutive ChangeNov 19, 2021

8-KExecutive ChangeSep 13, 2021

8-KExecutive ChangeJul 19, 2021

8-KExecutive ChangeJul 6, 2021

8-KMaterial AgreementApr 28, 2021

8-KMaterial AgreementDec 21, 2020

8-KReg FD DisclosureNov 16, 2020

8-KExecutive ChangeSep 2, 2020

8-KReg FD DisclosureApr 17, 2020

8-KExecutive ChangeApr 17, 2020

8-KChange of ControlNov 8, 2019

8-KAuditor ChangeNov 7, 2019

8-KExecutive ChangeOct 11, 2019

8-KExecutive ChangeOct 7, 2019

8-KExecutive ChangeOct 3, 2019

8-KAuditor ChangeJul 23, 2019

8-KExecutive ChangeJun 25, 2019

8-KMaterial Agreement · Equity IssuanceFeb 13, 2019

8-KMaterial Agreement · Equity IssuanceSep 27, 2018

8-KMaterial AgreementAug 14, 2018

8-KMaterial AgreementMay 2, 2018

8-KExecutive ChangeFeb 14, 2018

8-KExecutive ChangeJan 30, 2018

8-KMaterial AgreementDec 19, 2017

8-KAuditor ChangeNov 13, 2017

8-KExecutive ChangeNov 13, 2017

8-KMaterial AgreementMay 10, 2017

8-KExecutive ChangeDec 13, 2016

8-KAuditor ChangeMar 22, 2016

8-KMaterial AgreementFeb 22, 2016

8-KExecutive Change · Material AgreementJan 29, 2016

8-KRestatementOct 13, 2015

8-KMaterial AgreementOct 8, 2015

8-KReg FD DisclosureMay 28, 2015

8-KExecutive ChangeApr 9, 2015

8-KMaterial AgreementFeb 17, 2015

8-KMaterial AgreementFeb 3, 2015

8-KExecutive ChangeJan 23, 2015

8-KMaterial AgreementJan 6, 2015

8-KCompany UpdateDec 16, 2014

8-KMaterial AgreementNov 5, 2014

8-KReg FD DisclosureAug 1, 2014

8-KMaterial AgreementJul 25, 2014

8-KBylaw AmendmentJun 20, 2014

8-KChange of Control · Executive ChangeApr 30, 2014

8-KAcquisition / DispositionApr 8, 2014

8-KBylaw AmendmentDec 9, 2013

8-KMaterial Agreement · Agreement TerminatedNov 25, 2013

8-KMaterial AgreementOct 29, 2013

8-KReg FD DisclosureOct 22, 2013

8-KMaterial Agreement · Equity IssuanceJul 2, 2013

8-KEquity IssuanceJun 28, 2013

8-KExecutive ChangeAug 28, 2012

8-KExecutive ChangeJul 27, 2012

8-KExecutive ChangeApr 17, 2012

8-KChange of Control · Material AgreementNov 14, 2011

8-KAuditor ChangeNov 14, 2011

8-KExecutive Change · Agreement TerminatedNov 7, 2011

8-KExecutive Change · Reg FD DisclosureJul 5, 2011

8-KAuditor ChangeJun 29, 2011

8-KMaterial Agreement · New Debt / ObligationJun 20, 2011

8-KChange of Control · Executive ChangeJun 7, 2011

8-KSecurity-Holder Rights · Bylaw AmendmentMay 13, 2011

8-KBylaw Amendment · Company UpdateMay 10, 2011

8-KMaterial Agreement · Equity IssuanceApr 22, 2011

8-KBylaw AmendmentSep 30, 2010

8-KAcquisition / Disposition · Reg FD DisclosureDec 1, 2009

8-KMaterial AgreementMay 27, 2009

8-KExecutive ChangeAug 28, 2007

$444.2M

+9.3%

CLNNClene Inc.$74.6M-2.8%